STRATTAN CE RICK 4
4 · Cyclo Therapeutics, Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
STRATTAN CE RICK
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2023-10-27+42,599→ 271,424 total
Footnotes (1)
- [F1]Represents shares of common stock issued in lieu of cash compensation to the Reporting Person for consulting services rendered to the Issuer through September 30, 2023 valued at $40,000. The number of shares received in lieu of cash was calculated based on the closing price of $0.939 per share of the Issuer's common stock on October 27, 2023.